Literature DB >> 10504371

Local recurrence after curative excision of the rectum for cancer without adjuvant therapy: role of total anatomical dissection.

E L Bokey1, B Ojerskog, P H Chapuis, O F Dent, R C Newland, G Sinclair.   

Abstract

BACKGROUND: The wide variability of reported local recurrence rates after curative resection of rectal cancer without adjuvant therapy may be a consequence of many different factors. However, few studies have investigated the potential effects of such factors on local recurrence by multivariate analysis. The present study examined clinical and tumour characteristics, operation type and operative technique as potential predictors of local recurrence in patients treated by surgery alone.
METHODS: Prospective data were analysed by bivariate and multivariate methods including actuarial survival and proportional hazards regression.
RESULTS: Local recurrence (pelvic or pelvic and systemic) was diagnosed in 59 of 596 patients. The 5-year actuarial local recurrence rate was 11.1 (95 per cent confidence interval 8.7-14.3) per cent. Independent predictive factors for local recurrence were: positive nodes (hazard ratio (HR) 5.5, P < 0.01); distal margin of 1 cm or less (HR 3.8, P < 0.01); venous invasion (HR 2.0, P = 0.02) and total anatomical dissection of the rectum (HR 2.0, P = 0.01). There was no difference in local recurrence between patients who had the mesorectum divided and those in whom it was totally excised.
CONCLUSION: Nodal involvement is the most potent predictor of local recurrence. In patients in whom total anatomical dissection is performed, total mesorectal excision confers no additional protection against local recurrence.

Entities:  

Mesh:

Year:  1999        PMID: 10504371     DOI: 10.1046/j.1365-2168.1999.01216.x

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  33 in total

1.  Surgery of rectal cancer: still not a science.

Authors:  Federico Bozzetti
Journal:  Int J Colorectal Dis       Date:  2003-10-03       Impact factor: 2.571

2.  Redo-surgery by transanal colonic pull-through for failed anastomosis associated with chronic pelvic sepsis or rectovaginal fistula.

Authors:  Léon Maggiori; Julien Blanche; Yann Harnoy; Marianne Ferron; Yves Panis
Journal:  Int J Colorectal Dis       Date:  2015-01-15       Impact factor: 2.571

Review 3.  Adequate length of the distal resection margin in rectal cancer: from the oncological point of view.

Authors:  In Ja Park; Jin Cheon Kim
Journal:  J Gastrointest Surg       Date:  2010-02-09       Impact factor: 3.452

4.  Local recurrence and survival after laparoscopic mesorectal resection forrectal adenocarcinoma.

Authors:  E C Poulin; C M Schlachta; R Grégoire; P Seshadri; M O Cadeddu; J Mamazza
Journal:  Surg Endosc       Date:  2002-02-28       Impact factor: 4.584

Review 5.  Sphincter saving rectum resection is the standard procedure for low rectal cancer.

Authors:  E Di Betta; A D'Hoore; L Filez; F Penninckx
Journal:  Int J Colorectal Dis       Date:  2003-02-20       Impact factor: 2.571

Review 6.  Proforma-based reporting in rectal cancer.

Authors:  F Taylor; N Mangat; I R Swift; G Brown
Journal:  Cancer Imaging       Date:  2010-10-04       Impact factor: 3.909

Review 7.  Ultra-low anterior resection for low rectal cancer: five key tips to make it easy.

Authors:  F Seow-Choen
Journal:  Tech Coloproctol       Date:  2009-03-14       Impact factor: 3.781

8.  Anastomotic leakage is predictive of diminished survival after potentially curative resection for colorectal cancer.

Authors:  Kenneth G Walker; Stephen W Bell; Matthew J F X Rickard; Daniel Mehanna; Owen F Dent; Pierre H Chapuis; E Leslie Bokey
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

9.  [Problems in the treatment of upper rectal carcinoma].

Authors:  T Junginger; P Hermanek
Journal:  Chirurg       Date:  2008-04       Impact factor: 0.955

10.  Close distal margins do not increase rectal cancer recurrence after sphincter-saving surgery without neoadjuvant therapy.

Authors:  Jason Wei-Min Lim; Min-Hoe Chew; Kiat-Hon Lim; Choong-Leong Tang
Journal:  Int J Colorectal Dis       Date:  2012-08-24       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.